Cmax is out of the range [Study As­sess­ment]

posted by jag009  – NJ, 2018-08-02 17:56 (789 d 00:47 ago) – Posting: # 19128
Views: 2,640


» We recently conducted a BE trial. It was a classical 2-period, 2-sequence study of a drug that consists of a combination of two active substances. Unfortunately, results one of analytes, a parent drug, fell sightly outside of the 80-125% range, below 80% for Cmax. CV was below 30% and post-hoc power was less than 80% for this analyte...

Sorry, there is no way for you to argue.

Complete thread:

 Admin contact
21,086 posts in 4,398 threads, 1,468 registered users;
online 7 (1 registered, 6 guests [including 3 identified bots]).
Forum time: Tuesday 18:43 CEST (Europe/Vienna)

To know the history of science is to recognize the mortality
of any claim to universal truth.    Evelyn Fox Keller

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz